AXMIN Inc V.AXM.H

Alternate Symbol(s): AXMIF

Metals & Mining Gold

AXMIN Inc. is a Canadian exploration and development company with a focus on Central and West Africa. The Company, through its wholly owned subsidiaries, has exploration projects in the Central African Republic (CAR) and Senegal. The Company’s primary asset is the Passendro Gold Project situated in the CAR. It holds a 100% interest in the Bambari properties, which consists of a mining license (355 square kilometers) and two exploration licenses, Bambari 1 and 2 (1,240 square kilometers). The Passendro Gold Project is situated in the center of the mining license, which is ring-fenced by the two Bambari exploration licenses. The Company, through its joint venture partner and manager, Sabodala Mining Company SARL (SMC) owns approximately 20% interest in Sounkounkou, Heremokono and Sabodala NW exploration licenses (the Project) located in the Birimian belt of eastern Senegal. The Company's subsidiaries include AXMIN Limited (BVI), Aurafrique SARL (CAR), SOMIO Toungou SA (CAR), and others.

TSXV:AXM.H - Post by User

AXMIN Inc

Bullboard Posts

Comment by Alex77on Jun 25, 2018 3:37pm

60 Views

Post# 28225894

RE:Global Recession Will Trigger Huge Gold Price Spike

3 Gold Experts Share Bullish Price Predictions

Olivia Da Silva - March 13th, 2018

Industry heavyweights David Morgan, Rob McEwen and John Kaiser share their thoughts on how high the gold price could eventually go.

At this year’s PDAC convention in Toronto, experts David Morgan, Rob McEwen and John Kaiser shared their thoughts on gold’s long-term price potential.

They each gave their input on how high the yellow metal could go in the coming years, with some gold experts giving estimates of up to $10,000 per ounce — much higher than the current price of about $1,325.

Morgan, who publishes the Morgan Report and is best known for his commentary on silver, said gold could rise as high as $10,000 in the future, explaining that the outlook has a historical basis.

Bullboard Posts

The top 10 Canadian medical stocks